Cargando…
Antibody response to 2- and 3-dose SARS-CoV-2 mRNA vaccination in pediatric and adolescent kidney transplant recipients
BACKGROUND: Additional “booster” doses of mRNA SARS-CoV-2 vaccines have become standard of care for immunosuppressed patients, including kidney transplant recipients (KTR). While these additional doses have been shown to be efficacious in the adult KTR population, there is paucity of data for pediat...
Autores principales: | Crane, Clarkson, Phebus, Erin, Ingulli, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244318/ https://www.ncbi.nlm.nih.gov/pubmed/35759003 http://dx.doi.org/10.1007/s00467-022-05661-8 |
Ejemplares similares
-
Immunologic response of mRNA SARS-CoV-2 vaccination in adolescent kidney transplant recipients
por: Crane, Clarkson, et al.
Publicado: (2021) -
Prevention, diagnosis, and management of donor derived infections in pediatric kidney transplant recipients
por: Epperson, Katrina, et al.
Publicado: (2023) -
A045 INADEQUATE SARS-COV-2 ANTIBODY RESPONSE TO MRNA SARS-COV-2 VACCINE IN ADOLESCENT KIDNEY TRANSPLANT RECIPIENTS
por: Loop, L., et al.
Publicado: (2021) -
Response to: Focal segmental glomerulosclerosis recurrence in a young adult with kidney transplant after mRNA COVID-19 vaccination
por: Crane, Clarkson, et al.
Publicado: (2022) -
Weak antibody response to three doses of mRNA vaccine in kidney transplant recipients treated with belatacept
por: Chavarot, Nathalie, et al.
Publicado: (2021)